TRIOXBIO

The mission of TrioxBio Inc. is a steadfast dedication to the development and commercialization of proprietary synthetic small molecules to treat pathologic states caused by the overproduction of Nitric Oxide (NO). Our company has conducted numerous clinical trials demonstrating the safety and efficacy of its lead candidate, and believes it is developing the most effective NOS inhibitor to date... TrioxBio Inc., a Delaware Corporation, is a clinical-stage biotech company specializing in the development of compounds to treat diseases and medical conditions related to the pathological overproduction of Nitric Oxide (NO)-link to Nitric Oxide page. Over 100 white papers and articles have been published documenting how the overproduction of nitric oxide is linked to harmful effects on the human body and strongly believed to be responsible for numerous medical conditions, such as migraine-link to migraine section, cluster headache-link to cluster headaches section, intradialytic..

Also known as: TrioxBio Inc.